Endothelium-dependent effects of converting-enzyme inhibitors.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 7508046)

Published in J Cardiovasc Pharmacol on January 01, 1993

Authors

P M Vanhoutte1, C M Boulanger, S C Illiano, T Nagao, M Vidal, J V Mombouli

Author Affiliations

1: Center for Experimental Therapeutics, Baylor College of Medicine, Houston, TX 77030.

Articles by these authors

(truncated to the top 100)

Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61

GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol (2000) 7.46

Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet (2001) 7.16

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32

Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10

A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature (1989) 4.17

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev (1998) 4.06

Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat Genet (2001) 4.03

Geoelectric potential changes: possible precursors to earthquakes in Japan. Proc Natl Acad Sci U S A (2000) 3.93

The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75

Identification of a family of human F-box proteins. Curr Biol (1999) 3.31

Electric and magnetic phenomena observed before the volcano-seismic activity in 2000 in the Izu Island Region, Japan. Proc Natl Acad Sci U S A (2002) 3.18

High-throughput yeast two-hybrid assays for large-scale protein interaction mapping. Methods (2001) 3.09

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99

RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev (1996) 2.92

Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91

Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82

A protein-protein interaction map of the Caenorhabditis elegans 26S proteasome. EMBO Rep (2001) 2.74

Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69

Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J (1990) 2.56

A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A (1996) 2.54

Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53

The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol Cell Biol (1989) 2.52

Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast (2000) 2.51

The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol (1996) 2.43

Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet (1993) 2.40

Protein interaction maps for model organisms. Nat Rev Mol Cell Biol (2001) 2.32

Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway. Genes Dev (1997) 2.26

Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development (2001) 2.21

RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J (1999) 2.11

A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis (2011) 2.02

[Evaluation of functional capability after hospital admission of nonagenarian patients]. Med Clin (Barc) (2000) 2.01

Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation (1991) 1.96

Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A (1998) 1.92

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med (2000) 1.79

G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature (2000) 1.68

Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain. EMBO J (1997) 1.67

Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci (1996) 1.67

High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. Genes Dev (1989) 1.63

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ (2008) 1.58

Microparticles and type 2 diabetes. Diabetes Metab (2008) 1.57

Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development (2000) 1.50

Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke (1998) 1.46

Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest (1993) 1.46

Production of monoclonal antibodies against mammalian Ring1B proteins. Hybridoma (2001) 1.44

Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest (1997) 1.44

Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci U S A (1996) 1.42

Bacteriophage distribution in human faeces: continuous survey of healthy subjects and patients with internal and leukaemic diseases. J Gen Virol (1983) 1.42

Effects of trimebutine maleate on gastric motility in patients with gastric ulcer. J Gastroenterol (1998) 1.41

Blood hepatocyte growth factor levels in chronic renal failure patients. Nephron (1994) 1.41

Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex. Mol Biol Cell (2001) 1.41

New best estimates for radionuclide solid-liquid distribution coefficients in soils. Part 3: miscellany of radionuclides (Cd, Co, Ni, Zn, I, Se, Sb, Pu, Am, and others). J Environ Radioact (2008) 1.40

Flow cytometric analysis of cell-surface antigen expressions on acute myeloid leukemia cell populations according to their cell-size. Leuk Res (1994) 1.40

The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. Mol Pharmacol (1998) 1.40

Olfactory marker protein gene: its structure and olfactory neuron-specific expression in transgenic mice. Proc Natl Acad Sci U S A (1989) 1.37

Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur J Biochem (2000) 1.35

Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res (1992) 1.34

Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 1.34

Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human beta2-adrenoceptor contributes to agonist binding and receptor activation. Br J Pharmacol (1999) 1.33

Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol (1997) 1.32

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

A genetic strategy to eliminate self-activator baits prior to high-throughput yeast two-hybrid screens. Genome Res (1999) 1.28

Endothelium-derived contracting factors. Hypertension (1992) 1.27

Conformation and dynamics of melittin bound to magnetically oriented lipid bilayers by solid-state (31)P and (13)C NMR spectroscopy. Biophys J (2000) 1.24

Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.23

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci U S A (1995) 1.22

Role of microparticles in atherothrombosis. J Intern Med (2008) 1.21

Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20

Prediction of trace element mobility in contaminated soils by sequential extraction. J Environ Qual (2003) 1.19

Drug effect in acute leukemia. J Clin Invest (1969) 1.18

Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod (1998) 1.18

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM (2009) 1.17

Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol. Mol Pharmacol (1998) 1.17

Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. Blood (1998) 1.17

Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives. J Nat Prod (2000) 1.16

Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.15

One hundred hepatic resections. Indications and operative results. Ann Surg (1985) 1.14

Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res (2001) 1.14

Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol (2007) 1.13

Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis (1997) 1.13

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

Genetic control of development of the mushroom bodies, the associative learning centers in the Drosophila brain, by the eyeless, twin of eyeless, and Dachshund genes. Proc Natl Acad Sci U S A (2000) 1.12

A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein. Virology (1998) 1.12

Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A (2001) 1.11

A new classification of cerebral palsy based upon neurophysiologic considerations. Confin Neurol (1965) 1.11

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol (2011) 1.10

Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401). Arzneimittelforschung (1971) 1.10

Surgical resection for small hepatocellular carcinoma. Surgery (1996) 1.10

The second nation-wide survey in Japan of vitamin K deficiency in infancy. Eur J Pediatr (1988) 1.10

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. Ann Oncol (2011) 1.09

Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol (2000) 1.09

Studies on a new 1,5-benzothiazepine derivative (CRD-401). 3. Effects of optical isomers of CRD-401 on smooth muscle and other pharmacological properties. Jpn J Pharmacol (1972) 1.08

Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract (2006) 1.08

Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08

Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol (1991) 1.07

A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J (1999) 1.07

Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06